Patent holdings for IPC class C07D 305/14

Total number of patents in this class: 306

10-year publication summary

14
17
16
12
16
8
8
13
13
5
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Indena S.p.A.
626
12
Nektar Therapeutics
437
7
Aventis Pharma S.A.
51
6
Fresenius Kabi Oncology Limited
67
6
Novomer, Inc.
212
6
Alethia Biotherapeutics Inc.
18
5
Shenyang Pharmaceutical University
115
5
Starpharma Pty Limited
66
5
The University of British Columbia
1538
5
Shanghai Parling Pharma-Tech. Co., Ltd.
5
5
6570763 Canada Inc.
4
4
Hanmi Pharm. Co., Ltd.
581
4
The Research Foundation for The State University of New York
1667
4
Shilpa Medicare Limited
111
4
Tapestry Pharmaceuticals, Inc.
25
4
AstraZeneca AB
2857
3
Life Technologies Corporation
3351
3
Dalian Institute of Chemical Physics, Chinese Academy of Sciences
679
3
Inner Mongolia Puyin Pharmaceutical Co., Ltd
10
3
Institute of Materia Medica, Chinese Academy of Medical Sciences
183
3
Other owners 209